What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it? (Q40055789)
Jump to navigation
Jump to search
scientific article published on 22 August 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it? |
scientific article published on 22 August 2008 |
Statements
1 reference
What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it? (English)
1 reference
1 reference
Nina R Schooler
1 reference
Amir H Kalali
1 reference
Larry Alphs
1 reference
Ravi Anand
1 reference
George Awad
1 reference
Michael Davidson
1 reference
Sanjay Dubé
1 reference
Larry Ereshefsky
1 reference
Georges Gharabawi
1 reference
Andrew C Leon
1 reference
Jean-Pierre Lepine
1 reference
An Vermeulen
1 reference
22 August 2008
1 reference
1 reference
36
1 reference
3
1 reference
504-509
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference